Gene One Life Science unit VGXI extends buyback option on Conroe plant to Dec. 15 for USD 39.9 million
Bitget2026/09/23 05:32- Gene One Life Science’s unit VGXI extended the buyback-option window tied to its Conroe Plant 2 deed-in-lieu financing.
- New option maturity set for Dec. 15, 2026, from Sept. 1, 2026, extending the deadline by about 3.5 months.
- Total buyback price set at USD 39.9 million, including amounts for accrued interest, fees, lease costs, holding costs, premium.
- Payment schedule calls for USD 2 million on Oct. 7, USD 2 million on Oct. 30, balance USD 35.9 million on Dec. 15.
- Board decision date for the extension agreement: Sept. 23, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Crypto prices
More
